Yang Shi
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
- Biomaterials 39
- Nanoparticle-Based Drug Delivery 33
-
- Nanoplatforms for cancer theranostics 27
- Ultrasound and Hyperthermia Applications 7
- Co-authors
- Twan Lammers (44 shared papers)Fabian M. Kiessling (29 shared papers)Roy van der Meel (4 shared papers)Wim E. Hennink (27 shared papers)Willem J. M. Mulder (1 shared paper)Einar Sulheim (1 shared paper)Gerrit Storm (13 shared papers)Cornelus van Nostrum (13 shared papers)
- Journals
- Journal of Controlled Release (13 papers)Biomacromolecules (5 papers)Theranostics (4 papers)Advanced Materials (4 papers)Advanced Therapeutics (3 papers)
- Partner nations
- ChinaGermanyNetherlands
In The Last Decade
Yang Shi
118 papers receiving 7.7k citations
Yang Shi's Hit Papers
Peers
Comparison fields: 5 of 152
- Biomaterials 2.9k
- Biomedical Engineering 3.3k
- Pharmaceutical Science 365
- Immunology 1.1k
- Molecular Medicine 190
Countries citing papers authored by Yang Shi
This map shows the geographic impact of Yang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Shi more than expected).
Fields of papers citing papers by Yang Shi
This network shows the impact of papers produced by Yang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Shi. The network helps show where Yang Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Smart cancer nanomedicine Hit paper breakdown → | 2019 | 1035 |
| 2 | The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy Hit paper breakdown → | 2020 | 719 |
| 3 | PLGA-Based Nanoparticles in Cancer Treatment Hit paper breakdown → | 2018 | 483 |
| 4 | Combining Nanomedicine and Immunotherapy Hit paper breakdown → | 2019 | 404 |
| 5 | 2017 | 229 | |
| 6 | 2021 | 216 | |
| 7 | 2016 | 215 | |
| 8 | 2015 | 201 | |
| 9 | 2013 | 198 | |
| 10 | 2022 | 194 | |
| 11 | 2016 | 191 | |
| 12 | 2017 | 180 | |
| 13 | 2016 | 154 | |
| 14 | 2017 | 149 | |
| 15 | 2018 | 140 | |
| 16 | 2019 | 139 | |
| 17 | 2019 | 135 | |
| 18 | 2020 | 135 | |
| 19 | 2018 | 119 | |
| 20 | 2022 | 105 |
About Yang Shi
Yang Shi is a scholar working on Biomaterials, Biomedical Engineering, Immunology, Organic Chemistry and Oncology, having authored 121 papers that have together received 7.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (33 papers), Nanoplatforms for cancer theranostics (27 papers), Immunotherapy and Immune Responses (14 papers), Advanced Polymer Synthesis and Characterization (13 papers), RNA Interference and Gene Delivery (11 papers), CAR-T cell therapy research (7 papers), Ultrasound and Hyperthermia Applications (7 papers) and Lanthanide and Transition Metal Complexes (7 papers). The work is most often cited by research in Biomaterials (2.9k citations), Biomedical Engineering (3.3k citations), Pharmaceutical Science (365 citations), Immunology (1.1k citations) and Molecular Medicine (190 citations). Yang Shi has collaborated with scholars based in China, Germany and Netherlands. Frequent co-authors include Twan Lammers, Fabian M. Kiessling, Roy van der Meel, Wim E. Hennink, Willem J. M. Mulder, Einar Sulheim, Gerrit Storm, Cornelus van Nostrum, Vertika Pathak and Tarun Ojha. Their work appears in journals such as Journal of Controlled Release, Biomacromolecules, Theranostics, Advanced Materials and Advanced Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.